MMP9 and laryngotracheoesophageal cleft: After a survival analysis, and drug–target–pathway analysis, five hub genes (HSP90AA1, ESR1, CYP3A4, CDK1, and MMP9) were discovered to be involved in the overall survival of LC patients.